Co-Authors
This is a "connection" page, showing publications co-authored by Benjamin Pinsky and Scott Boyd.
Connection Strength
1.670
-
Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results. Clin Chem. 2021 07 06; 67(7):977-986.
Score: 0.239
-
Evaluation of SARS-CoV-2 total antibody detection via a lateral flow nanoparticle fluorescence immunoassay. J Clin Virol. 2021 06; 139:104818.
Score: 0.234
-
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Sci Immunol. 2020 12 07; 5(54).
Score: 0.229
-
Large-Scale Testing of Asymptomatic Healthcare Personnel for Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2021 Jan; 27(1).
Score: 0.229
-
Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2. Cell Host Microbe. 2020 10 07; 28(4):516-525.e5.
Score: 0.225
-
SARS-CoV-2 RNAemia in a Healthy Blood Donor 40 Days After Respiratory Illness Resolution. Ann Intern Med. 2020 11 17; 173(10):853-854.
Score: 0.223
-
SARS-CoV-2 IgG Seropositivity and Acute Asymptomatic Infection Rate among Firefighter First Responders in an Early Outbreak County in California. Prehosp Emerg Care. 2021 May 06; 1-10.
Score: 0.059
-
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series. EBioMedicine. 2021 May; 67:103355.
Score: 0.059
-
Plasma as an alternative COVID-19 diagnostic specimen in a hospitalized patient negative for SARS-CoV-2 by nasopharyngeal swab. Diagn Microbiol Infect Dis. 2021 Jul; 100(3):115365.
Score: 0.058
-
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021 09; 42(9):1053-1059.
Score: 0.057
-
Proinflammatory IgG Fc structures in patients with severe COVID-19. Nat Immunol. 2021 01; 22(1):67-73.
Score: 0.057